Article Versions Notes

Fiore JR, Di Stefano M, Oler A, Zhang Y, Gu J, Dalgard CL, Faleo G, Epling B, Notarangelo L, Lisco A, et al. Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19. Viruses. 2023; 15(7):1448. https://doi.org/10.3390/v15071448

Fiore, Josè R., Mariantonietta Di Stefano, Andrew Oler, Yu Zhang, Jingwen Gu, Clifton L. Dalgard, Giuseppina Faleo, Brian Epling, Luigi Notarangelo, Andrea Lisco, and et al. 2023. "Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19" Viruses 15, no. 7: 1448. https://doi.org/10.3390/v15071448

Fiore, J. R., Di Stefano, M., Oler, A., Zhang, Y., Gu, J., Dalgard, C. L., Faleo, G., Epling, B., Notarangelo, L., Lisco, A., & Santantonio, T. A. (2023). Lack of Evidence for a Role of ACE-2 Polymorphisms as a Bedside Clinical Prognostic Marker of COVID-19. Viruses, 15(7), 1448. https://doi.org/10.3390/v15071448